These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15640842)

  • 1. Polo-like kinases and oncogenesis.
    Eckerdt F; Yuan J; Strebhardt K
    Oncogene; 2005 Jan; 24(2):267-76. PubMed ID: 15640842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions.
    Bahassi el M
    Exp Biol Med (Maywood); 2011 Jun; 236(6):648-57. PubMed ID: 21558091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinases and the microtubule organization center: targets for cancer therapies.
    Dai W; Cogswell JP
    Prog Cell Cycle Res; 2003; 5():327-34. PubMed ID: 14593727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting in and out of mitosis with Polo-like kinase-1.
    van Vugt MA; Medema RH
    Oncogene; 2005 Apr; 24(17):2844-59. PubMed ID: 15838519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization.
    Leung GC; Hudson JW; Kozarova A; Davidson A; Dennis JW; Sicheri F
    Nat Struct Biol; 2002 Oct; 9(10):719-24. PubMed ID: 12352953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
    Winkles JA; Alberts GF
    Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
    Pellegrino R; Calvisi DF; Ladu S; Ehemann V; Staniscia T; Evert M; Dombrowski F; Schirmacher P; Longerich T
    Hepatology; 2010 Mar; 51(3):857-68. PubMed ID: 20112253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.
    Conn CW; Hennigan RF; Dai W; Sanchez Y; Stambrook PJ
    Cancer Res; 2000 Dec; 60(24):6826-31. PubMed ID: 11156373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polo-like kinases (Plks) and cancer.
    Takai N; Hamanaka R; Yoshimatsu J; Miyakawa I
    Oncogene; 2005 Jan; 24(2):287-91. PubMed ID: 15640844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cell cycle checkpoints by polo-like kinases.
    Xie S; Xie B; Lee MY; Dai W
    Oncogene; 2005 Jan; 24(2):277-86. PubMed ID: 15640843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.
    Yuan J; Krämer A; Eckerdt F; Kaufmann M; Strebhardt K
    Cancer Res; 2002 Aug; 62(15):4186-90. PubMed ID: 12154015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast polo-like kinases: functionally conserved multitask mitotic regulators.
    Lee KS; Park JE; Asano S; Park CJ
    Oncogene; 2005 Jan; 24(2):217-29. PubMed ID: 15640837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-mitotic functions of polo-like kinases in cancer cells.
    Raab CA; Raab M; Becker S; Strebhardt K
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188467. PubMed ID: 33171265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Plk3 in oncogenesis.
    Helmke C; Becker S; Strebhardt K
    Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polo-like kinases in the nervous system.
    Seeburg DP; Pak D; Sheng M
    Oncogene; 2005 Jan; 24(2):292-8. PubMed ID: 15640845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide.
    Kim SM; Yoon S; Choi N; Hong KS; Murugan RN; Cho G; Ryu EK
    Biomaterials; 2012 Oct; 33(29):6915-25. PubMed ID: 22795848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plk3-Cdc25 circuit.
    Myer DL; Bahassi el M; Stambrook PJ
    Oncogene; 2005 Jan; 24(2):299-305. PubMed ID: 15640846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the Plk4/Sak consensus phosphorylation motif using peptide spots arrays.
    Leung GC; Ho CS; Blasutig IM; Murphy JM; Sicheri F
    FEBS Lett; 2007 Jan; 581(1):77-83. PubMed ID: 17174311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
    Reindl W; Gräber M; Strebhardt K; Berg T
    Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinases: a team in control of the division.
    van de Weerdt BC; Medema RH
    Cell Cycle; 2006 Apr; 5(8):853-64. PubMed ID: 16627997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.